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Detection of Nighttime Melatonin Level in Chinese
Original Quiet Sitting
Chien-Hui Liou,1 Chang-Wei Hsieh,2,3 Chao-Hsien Hsieh,1,4 Der-Yow Chen,1,5 Chi-Hong Wang,6
Jyh-Horng Chen,1†* Si-Chen Lee7*†
Background/Purpose: Some research has shown that melatonin levels increase after meditation practices,
but other research has shown that they do not. In our previous functional magnetic resonance imaging
study, we found positive activation of the pineal body during Chinese Original Quiet Sitting (COQS). To
find other supporting evidence for pineal activation, the aim of this study was to evaluate the effect of
COQS on nighttime melatonin levels.
Methods: Twenty subjects (11 women and 9 men, aged 29–64 years) who had regularly practiced daily med-
itation for 5–24 years participated in this study. All subjects served alternately as participants in the medi-
ation and control groups. COQS was adopted in this study. Tests were performed during two nighttime
sessions. Saliva was sampled at 0, 10, 20, 30, 45, 60 and 90 minutes after COQS and tested for level of melan-
tonin. Time period effect analysis and mixed effect model analysis were preceded by paired t test analysis.
Results: In the meditation group (n = 20), the mean level of melatonin was significantly higher than the base-
line level at various times post-meditation (p < 0.001). Within the control group (n = 20), the mean level of
melatonin at various times was not significantly different compared with baseline (p > 0.05). These results
suggested that the melatonin level was statistically elevated in the meditation group and almost unchanged in
the control group after nighttime meditation. The urine serotonin levels detected by measuring 5-hydroxy-
indole-3-acetic acid levels were also studied, but no detectable difference between the groups was found.
Conclusion: Our results support the hypothesis that meditation might elevate the nighttime salivary
melatonin levels. It suggests that COQS can be used as a psychophysiological stimulus to increase endogenous
secretion of melatonin, which in turn, might contribute to an improved sense of well-being.
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Chinese Original Quiet Sitting (COQS) is a type of
traditional Chinese meditation. In ancient China,
meditation was the principal practice used by
Taoists to temper the spirit and body. In our pre-
vious functional magnetic resonance imaging
(fMRI) study, we found positive activation of the
pineal body during this meditation practice.1 The
pineal body produces many substances, including
melatonin,2 and melatonin levels during COQS
have never been studied, therefore, we hypothe-
sized that COQS might also cause an increase in
melatonin levels. Furthermore, there have been
many studies on the physiological effects of mel-
atonin. As has been reported, melatonin is effec-
tive in reducing cancer development or the risk
of cancer mortality.3–5 It also has functional ef-
fects on cellular bioenergetics6 and cellular re-
gulation.7 In addition, it possesses antioxidant
effects,8–10 anti-aging properties,11 and locally re-
gulates human placental function.12 Circadian
rhythm corresponds to the secretion of mela-
tonin.13–17 Melatonin might also influence im-
mune function and seasonal fertility in some
animals.18,19 The potential interaction between
COQS, pineal activation and melatonin levels
becomes more interesting and important due to
these special physical effects of melatonin.
In recent years, meditation has become an in-
creasingly popular form of exercise worldwide.
Some religious people practice meditation on a
daily basis to improve their body, mind and
spirit. There are many different styles of medita-
tion. However, the mechanism by which medita-
tion improves health remains unclear. Massion
et al tested the hypothesis that the regular prac-
tice of mindfulness meditation is associated with 
increased physiological levels of melatonin, and
have obtained some positive results.20 Tooley et al
studied whether a period of meditation can in-
fluence melatonin levels. Transcendental Sidhi
and yoga meditation have also been studied and
their practice has been shown to result in signifi-
cantly higher plasma melatonin levels.21 Harinath
et al evaluated the effects of Hatha yoga and
Omkar meditation on cardiorespiratory perform-
ance and melatonin secretion. They found that
plasma melatonin levels increase after 3 months
of yoga.22 In contrast, Solberg et al studied mela-
tonin secretion during ACEM meditation (ACEM
is a meditation organization that originated in
Oslo, Norway), and although they have found that
advanced meditators have higher melatonin lev-
els than non-meditators, melatonin actually de-
creases during long-term meditation.23 Carlson
et al investigated the benefits of a mindfulness-
based stress reduction meditation program for
early-stage breast and prostate cancer patients, and
have found no overall changes in melatonin lev-
els.24 It appears that the secretion of melatonin
might depend on the style of meditation. There-
fore, it is necessary to determine whether night-
time salivary melatonin levels are elevated or
depressed after COQS.
Melatonin is synthesized endogenously from
the amino acid tryptophan (derived from 
serotonin) by the enzyme 5-hydroxyindole-O-
methyltransferase. Serotonin is a monoamine
neurotransmitter that is synthesized in seroton-
ergic neurons in the central nervous system and
enterochromaffin cells in the gastrointestinal tract.
Bujatti et al found a highly significant increase 
in 5-hydroxyindole-3-acetic acid (5-HIAA; the
main breakdown product of serotonin) in urine
after transcendental meditation.25 In contrast,
Solberg et al found that serotonin concentrations
decreased in meditation and reference groups
after 1 hour of meditation (p < 0.01).23 These con-
trasting results need to be examined further. 
Urine serotonin levels detected by 5-HIAA were
measured in our study. The aim of this study was




The overall COQS process is separated into two
distinct parts: (1) several minutes of silent recita-
tion of specific religious mantra and mental imag-
ination of receiving spiritual energy (which is
named “Invitation of Primordial Qi”: IPQ); and
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(2) a longer period of relaxation with no further
action of the mind and letting Qi do its work 
(referred to as “Allow its Natural Workings”:
ANW).26,27 Chen et al studied COQS using elec-
troencephalography and have found a marked
increase in brain θ-waves and decreased α- and
β-waves.28 We also carried out an fMRI study.1
Nighttime salivary melatonin levels during this
meditation practice were measured.
Salivary melatonin analysis
A number of biological fluids can be sampled as
sources of melatonin, including saliva, serum,
plasma, urine, sweat and tissue extracts. The most
direct and convenient way to measure melatonin
levels is through saliva analysis. For subject com-
fort and to minimize influencing the levels dur-
ing sampling, we performed the saliva sampling
as described below.
Experimental design
The test periods chosen were at night. The overall
sampling period was set to 90 minutes, including
10 minutes of rest for subjects to calm down, 5
minutes of IPQ, 30 minutes of ANW, and then a
resting state of 45 minutes. The sampling points
were set at 0, 10, 20, 30, 45, 60 and 90 minutes
from the beginning of the experiment (23:00)
(Figure 1). The salivary samples of the meditation
group members were obtained by the control
group members or other helpers.
Subjects and regulations
Twenty subjects (11 women and 9 men) partici-
pated in the meditation and control groups. All
subjects were in good health; exclusion criteria
included epilepsy, psychosis, diseases of the nerv-
ous system, and a history of head trauma. Before
our meditation experiments, all subjects were first
asked to read the experimental instructions and
were given an explanation of the test. Each subject
filled out the “Subject Information and Agreement
form”. After each test, a short discussion was held
to allow us to collect information on each sub-
ject’s situation and conditions. The mean age 
of the subjects was 52.17 ± 2.16 years [mean ±
standard error of the mean (SEM); range, 29–64
years], with meditation experience of 15.83 ± 1.42
(5–24) years. They practiced meditation every
day, 2.03 ± 0.16 (1–4) times, with a mean prac-
tice duration of 57.5 ± 3.98 (30–90) minutes each
time. Their average bedtime was 23.58 ± 0.14
(22.5–24.5) o’clock. Thirteen subjects were mem-
bers of religious groups (age, 29–63 years) and
lived in the Taoist Sanctuary. Seven subjects were
retired (age, 57–64 years). All subjects were 
well-trained meditators (Table 1).
Experiments were carried out over 2 days.
Different sleep/wake schedules might have dif-
ferent melatonin secretion profiles. Maintenance






Figure 1. The test periods adopted in the salivary mela-
tonin study of meditation practice. IPQ = Invitation of
Primordial Qi; ANW = Allow its Natural Workings.
Table 1. Information on the subjects and self-
evaluation of the effect of saliva sampling
operation during the meditation process
(n = 20)
Mean ± SEM (range)
What is your age? 52.17 ± 2.16 (29–64)
How many years have 15.83 ± 1.42 (5–24)
you practiced meditation?
How many times do you 2.03 ± 0.16 (1–4)
practice every day?
How long do you practice 57.50 ± 3.98 (30–90)
each time? (min)
When do you go to bed 23.58 ± 0.14 (22.5–24.5)
each night? (o’clock)
Does the saliva sampling 2.25 ± 0.19 (1–5)
operation have any 
adverse effects on your 
meditation? (1–10 scale)*
*The scale numbers are set from 1 to 10, with a 1 meaning no 
effect at all and a 10 meaning a very seriously adverse effect.
Every subject was asked to give a score subjectively right at the
end of the experiment. SEM = Standard error mean.
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into consideration during the test to avoid diur-
nal changes in hormone levels, and to eliminate
misleading results from differences in subjects’
endogenous circadian phases. A proper period of
experiment was carefully chosen. As the average
bedtime of the subjects was around 23:35 hours,
all experimental procedures and apparatus were
prepared at 22:30 hours and performed between
23:00 and 00:30 hours. Furthermore, all subjects
participated in the meditation and control groups
during these 2 research days. Half of the subjects
who participated in the meditation group on the
first day were assigned to the control group on the
second day, and vice versa. Before the test, all sub-
jects were instructed to maintain their normal
daily activities, but not to meditate or eat in the 
3 hours before the experiment. Subjects were in-
structed to refrain from coffee, tea, and smoking
for at least 4 hours before the test, and to refrain
from alcohol and bananas for at least 24 hours
before the experiment. During the experimental
period, the meditation group was advised to stay
alert and not to fall asleep during this process.
The control group was advised to sit and rest in
the manner in which they preferred, but to avoid
talking, sleeping, or walking. Furthermore, when
the meditation group was in the IPQ stage, the con-
trol group was asked to recite one short poem
slowly. During the sampling period, there was no
verbal communication. Subjects refrained from eat-
ing and avoided beverages that contained artificial
colorants, as well as coffee or alcoholic beverages.
Light exposure control
All subjects were asked to reach the test room at
22:30 hours for preparation on the 2 experimen-
tal days. All subjects were in the same room; there-
fore, the light exposure of each individual subject
was controlled at the same level on these two ex-
perimental nights. During the period 22:50–23:00
hours, all subjects sat in the test room and verbal
communication was allowed with the light on.
The light was switched off in the test room at ex-
actly 23:00 hours and remained off until the end
of the experiment, which allowed only the light of
the corridor to pass through the windows. The first
10 minutes was a rest period for subjects to enable
them to calm down. No verbal communication
was allowed. The subsequent periods were COQS-
IPQ for 5 minutes, COQS-ANW for 30 minutes,
and 45 minutes for further rest. Light intensity
was carefully controlled and maintained at the
same level during these two dates. Light levels
were monitored throughout the experiment and
did not exceed 5 lux.
Sampling and data analysis
To test whether post-meditation melatonin lev-
els differed from baseline levels, saliva samples
were obtained using saliva collection tubes
(Salivette, Sarstedt Inc., Rommelsdorf, Germany)
and analyzed with competitive enzyme-linked
immunoassay (Direct Saliva Melatonin ELISA
kit; Buhlmann Laboratories, Schonenbuch,
Switzerland). Results were analyzed using CODA
Automated EIA Analyzer (Bio-Rad, Hercules, USA).
The means and SEM of each value of the sampling
data were first calculated. As a result of the re-
peated measurement design of our study, within-
subject data were assumed to be correlated. To
test the time period effect, a paired t test was per-
formed to compare the mean difference between
various time points [Post I: 10 < t ≤ 45 min (with 3
time points); Post: 10 < t ≤ 90 min (5 time points);
Post II: 45 < t ≤ 90 min (2 time points)] and the
baseline [Pre: 0 ≤ t ≤ 10 min (2 time points); the
average of data on 0 and 10 min] by treatment.
One-sided analysis of variance was used for hy-
pothesis testing for the treatment and time effects,
and the p values reported were one-sided.
Urine serotonin analysis
The main breakdown product of serotonin, 5-
HIAA, was analyzed in the urine samples of the
20 subjects. Each subject collected the urine in a
1.5-L bottle with 3 mL 6 N HCl within 6 hours of
the experiment on their mediation and control
dates. Samples were stored in a cold chamber kept
at < 5°C before being analyzed. The analytical
instrument adopted was the high-performance
liquid chromatography, which contained the sol-
vent and sample manager, column chamber and
C.H. Liou, et al
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detector. The concentrations of the sample con-
stituents were identified and quantified. Analytical
results of raw data and chromatography were
also obtained. Means and SEM of the data were
calculated as the final results.
Results
Subject self-evaluation
All subjects were asked to perform a self-evaluation
task after the experiments to ascertain whether
the saliva sampling operation had adverse effects
on their meditation. The scale numbers were set
from 1 to 10, with 1 meaning no effect and 10
meaning a very strong effect. Every subject was
asked to give a score immediately after the end of
the experiment. Although these scores might have
been arbitrary or subjective, they did provide cer-
tain information on what happened among the
subjects during the sampling operation. The
mean self-evaluation score was 2.25±0.19 (range,
1–5; Table 1), which suggested that the saliva
sampling operation had a slight effect on the sub-
jects during the meditation process. Most sub-
jects claimed that they were immediately able to
return to the good and positive meditating situa-
tion after each saliva sampling operation.
Salivary melatonin analysis
Upon processing the data from the melatonin ana-
lysis, we first dealt with the baseline homogeneity
analysis. The baseline values (average of data at 
0 and 10 min) in the meditation/control treat-
ment were 8.37 ± 2.13/5.65 ± 1.11, and the mean
baseline difference between meditation and con-
trol treatment was 2.72, with a paired t test p
value of 0.060, and the 95% confidence interval of
–0.12 to 5.56. We also applied a time point effect
analysis. Within the mediation treatment group,
the mean level of melatonin at various post-
meditation time points (Post I: 9.42 ± 2.44 pg/mL;
Post: 9.93 ± 2.39 pg/mL; Post II: 10.70 ± 2.42 pg/
mL) was significantly higher than baseline levels
(Pre: 8.37 ± 2.13 pg/mL), with p < 0.05 for “Post I”
and p < 0.001 for both “Post” and “Post II” peri-
ods. However, within the control treatment group,
the mean level of melatonin at various post time
points (Post I: 6.51 ± 1.50 pg/mL; Post: 6.70 ±
1.48 pg/mL; Post II: 6.97 ± 1.48 pg/mL) was not
significant (p > 0.05) in comparison to baseline
levels (Pre: 5.65±1.11pg/mL) (Table 2). The results
suggested that the melatonin level was signifi-
cantly elevated after meditation in the medita-
tion group and almost unchanged in the control
group. Figure 2 shows the results of analysis of
melatonin levels of the meditation group and the
control group. The p values of the meditation and
control groups between “Pre” and “Post I”, “Post”,
“Post II” are also shown.
Analysis of urine serotonin
The serotonin levels (urine 5-HIAA) of the medi-
tation and control groups for the 20 subjects were
Table 2. Results of the time point effect analysis on melatonin levels
Paired t test
Treatment Time period* Mean SEM
One-sided p 95% CI
Meditation Pre 8.37 2.13 — —
Post I 9.42 2.44 0.043 (0.05, ∝)
Post 9.93 2.39 < 0.001 (0.86, ∝)
Post II 10.70 2.42 < 0.001 (1.26, ∝)
Control Pre 5.65 1.11 — —
Post I 6.51 1.50 0.152 (−0.55, ∝)
Post 6.70 1.48 0.106 (−0.35, ∝)
Post II 6.97 1.48 0.064 (−0.12, ∝)
* Pre: 0 ≤ t ≤ 10 min; Post I: 10 < t ≤ 45 min; Post: 10 < t ≤ 90 min; Post II: 45 < t ≤ 90 min. SEM = Standard Error of the Mean; CI =
confidence interval.
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analyzed (Table 3). The results showed no statisti-
cal difference (p=0.22) between the 5-HIAA levels
in the meditation group (0.86 ± 0.10 mg/6 hr)
and the control group (0.96 ± 0.15 mg/6 hr).
Discussion
During the experimental process, we carefully
controlled the timing and light exposure and
each subject participated in the meditation and
control groups. Thus any misleading and negative
effect due to light-induced suppression and dif-
ferences in individual circadian cycles should
have been reduced. Our results exhibited statisti-
cal significance (with p < 0.05 for Post I and
p < 0.001 for Post and Post II periods) and sup-
port the hypothesis that COQS can elevate night-
time melatonin levels. These results also support
our previous fMRI observation of pineal activation
during COQS.1 All the information suggests that
COQS, pineal activation and melatonin levels
have a positive interaction, which implies that
COQS activates the pineal body and results in
nighttime secretion of melatonin. Massion et al,20
Tooley et al21 and Harinath et al22 also found ele-
vation of nighttime melatonin levels. Massion et al
measured urine melatonin, whereas Tooley et al
and Harinath et al measured plasma melatonin.
In our study, although the variation in salivary
melatonin levels was not as sensitive as in plasma,
salivary melatonin was still significantly increased
in COQS for well-trained meditators. As the
nighttime melatonin levels are elevated, medita-
tion might influence the effects of melatonin;
these include cancer prevention,3–5 influencing
cellular bioenergetics functions6 and cellular reg-
ulation,7 antioxidant effects,8–10 anti-aging prop-
erties,11 regulation of human placental function,12
circadian rhythm,13–17 immune function18,19 and
any other function that might relate to melatonin.
Revell et al published melatonin daily profiles
from their research of circadian phase determina-
tion.29 From these profiles, we see that the daily
melatonin levels are higher at midnight and lower
in the daytime. As we have already mentioned,
Solberg studied melatonin secretion during the
meditation process and found that melatonin is
decreased after long meditation.23 Perhaps this
discrepancy is due to the fact that they set the ex-
perimental period in the daytime (starting from
09:00 hours and lasting for 3 hours). The results of
samples taken during in a 3-hour daytime medi-
ation period might also need to be clarified. The
ultimate explanation of the decline in melatonin
levels, whether temporal or sampling, needs fur-
ther investigation. Carlson et al investigated a
mindfulness-based stress reduction meditation
program for early-stage breast and prostate cancer
patients, and found no overall changes in mela-
tonin.24 It is possible that the following two rea-
sons explain their findings: (1) the daytime
(14:00 hours) samples used in the melatonin
assay could have led to insignificant change; and
(2) their subjects were patients who attended a
short meditation training course (8 weeks), and
the duration of training could have been insuffi-






























Pre Post I Post Post II
Figure 2. Analysis of melatonin levels in the meditation
and control groups. The time periods were Pre: 0 ≤ t ≤ 10
minutes; Post I: 10 < t ≤ 45 minutes; Post: 10 < t ≤ 90 min-
utes; Post II: 45 < t ≤ 90 minutes. Error bars represent stan-
dard error of the mean.





Serotonin 0.86 ± 0.10 0.96 ± 0.15 0.22
(mg/6 hr)†
*Data presented as mean ± standard error mean; †urine sero-
tonin levels were analyzed using the samples of the 20 subjects.
Each subject collected all urine from the onset point until 6 hours
later, on both their mediation and control experiment days.
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reasons might have produced the similarities be-
tween the control and test groups. Further testing
of these hypotheses is now required. 
We also dealt with the mixed effect model
analysis. The results showed that the main effect of
treatment/time was not significant [F(1,171) =
1.09, p=0.300/F(4,171)=1.41, p=0.233]. The in-
teraction between treatment and time was also
not significant [F(4,171) = 0.29, p = 0.883]. All 20
subjects participated in the meditation and con-
trol groups, therefore, the “self-anticipating effect”
of the meditators (during the “Pre” state and wait-
ing for the meditation period) and the “regulated
routine effect” (the daily course and custom of a
well-trained meditator to participate in the control
group) might have played a role in our results.
Neither of these effects is believed to have led to
the significant difference between the meditation
and control groups.
In this study, we examined the influence of
COQS on nighttime salivary melatonin levels. Our
results suggest that nighttime melatonin level was
significantly elevated for the meditation group but
almost unchanged for the control group. This sup-
ports the hypothesis that this meditation practice
could elevate nighttime melatonin levels. These
results also support our previous fMRI observation
of positive activation of the pineal body during
meditation practices. All the information obtained
implies that meditation causes activation of the
pineal body, which results in secretion of night-
time melatonin, and which might also have cer-
tain physiological effects on the human body.
Further studies could be needed to establish the
circadian phase as a baseline for each individual,
and to determine more conclusively detailed
melatonin secretion profiles and daytime mela-
tonin levels under the influence of COQS.
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